Graanul Biotech OÜ – Trademark Portfolio
Entity Type: 16
Graanul Biotech OÜ holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FIBENOL and LIGNOVA. The owner is based in Tallinn.
Humala 2
Tallinn 10617 , EE
Showing of trademarks Trademarks
Trademark Classifications
Graanul Biotech OÜ's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Graanul Biotech OÜ have?
Graanul Biotech OÜ has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Graanul Biotech OÜ file in?
Graanul Biotech OÜ files trademarks across 5 Nice Classification classes. The most active classes are Class 19 (Building Materials), Class 1 (Chemicals), Class 4 (Lubricants & Fuels), Class 5 (Pharmaceuticals), Class 17 (Rubber Goods). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are Graanul Biotech OÜ's most well-known trademarks?
Graanul Biotech OÜ's registered trademark portfolio includes well-known marks such as FIBENOL and LIGNOVA. These are among 2 currently registered trademarks in the portfolio.
What is Graanul Biotech OÜ's trademark registration success rate?
Graanul Biotech OÜ has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.